Showing results (121-130 of 214) with videos related to
Sort By:
Pageof 22
Leukemia|March 1, 1996
Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID miceA K Palucka, R Scuderi, A Porwit, et al.Leukemia & Lymphoma|April 11, 2003
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemiaM J Keating, S O'Brien, D Kontoyiannis, et al.Blood|December 1, 1988
Detection of leukemic clone maturation in vivo by premature chromosome condensationW N Hittelman, P Agbor, I Petkovic, et al.Cancer|September 15, 1988
Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell lineA Eisbruch, M Blick, M J Evinger-Hodges, et al.Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|October 24, 2023
Depression in Uveal Melanoma Survivorship: Examining Psychological Predictors of Adjustment in the First Year Following DiagnosisMegan M Hoch, James J MacDonald, Alexandra Jorge-Miller, et al.Journal of Behavioral Medicine|September 17, 2020
A prospective study of cancer-related benefit finding in uveal melanoma patientsKate L Herts, Alexandra Jorge-Miller, Tammy M Beran, et al.Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.Cancer|November 15, 1993
Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remissionH M Kantarjian, E Estey, S O'Brien, et al.The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.Cancer Genetics and Cytogenetics|August 1, 1987
Molecular characteristics of chronic myelogenous leukemia in blast crisisM Blick, P Romero, M Talpaz, et al.Pageof 22